Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP618150.RAwCB9L16_GkIfpdq-S1rnULycjhziJaGlB1HodvxbPVk130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP618150.RAwCB9L16_GkIfpdq-S1rnULycjhziJaGlB1HodvxbPVk130_assertion type Assertion NP618150.RAwCB9L16_GkIfpdq-S1rnULycjhziJaGlB1HodvxbPVk130_head.
- NP618150.RAwCB9L16_GkIfpdq-S1rnULycjhziJaGlB1HodvxbPVk130_assertion description "[Comparison of the methylation level for the matched benign and prostate cancer tissues from individual patients with prostate cancer showed significantly higher methylation in the prostate cancer tissue samples for RARbeta2 (P < 0.001), RASSF1A (P = 0.005), GSTP1 (P < 0.001), NKX2-5 (P = 0.003), ESR1 (P = 0.016), and CLSTN1 (P = 0.01).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP618150.RAwCB9L16_GkIfpdq-S1rnULycjhziJaGlB1HodvxbPVk130_provenance.
- NP618150.RAwCB9L16_GkIfpdq-S1rnULycjhziJaGlB1HodvxbPVk130_assertion evidence source_evidence_literature NP618150.RAwCB9L16_GkIfpdq-S1rnULycjhziJaGlB1HodvxbPVk130_provenance.
- NP618150.RAwCB9L16_GkIfpdq-S1rnULycjhziJaGlB1HodvxbPVk130_assertion SIO_000772 17606710 NP618150.RAwCB9L16_GkIfpdq-S1rnULycjhziJaGlB1HodvxbPVk130_provenance.
- NP618150.RAwCB9L16_GkIfpdq-S1rnULycjhziJaGlB1HodvxbPVk130_assertion wasDerivedFrom befree-2016 NP618150.RAwCB9L16_GkIfpdq-S1rnULycjhziJaGlB1HodvxbPVk130_provenance.
- NP618150.RAwCB9L16_GkIfpdq-S1rnULycjhziJaGlB1HodvxbPVk130_assertion wasGeneratedBy ECO_0000203 NP618150.RAwCB9L16_GkIfpdq-S1rnULycjhziJaGlB1HodvxbPVk130_provenance.